Planned phase II trial of SPN 811 in patients with ADHD.
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2010
At a glance
- Drugs SPN 811 (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Supernus Pharmaceuticals
- 13 Jul 2010 New trial record
- 13 Jul 2010 This trial is expected to be initiated in 2011, according to a Supernus Pharmaceuticals media release.